Ciara

Quick links to important sections

Ciara

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ciara

What is Ciara? Overview

Property Description
Active Ingredient Calcium Pantothenate
Form Oral Tablet
Pharmacological Class Water-soluble Vitamin (B₅)
Common Use Micronutrient Supplementation
Origin Synthetic (derived)

What Type of Essential Supplement is Ciara?

Ciara is a commercial product based on the single active ingredient Calcium Pantothenate, which is formally classified as a micronutrient supplement and is universally known as Vitamin B₅. This compound belongs to the therapeutic group of water-soluble vitamins within the B-complex group, distinguishing it from conventional pharmaceuticals used for acute disease treatment. As an essential nutrient, Ciara provides the body with a vital substance it cannot produce internally, a fact clinically recognized across numerous nutritional guidelines. The product is designed for oral intake, presenting the active substance in a highly stable, single-ingredient tablet form, commonly appealing to adult patient groups interested in sustained cellular health.


Ciara's Composition and General Purpose

The active component in Ciara is Calcium Pantothenate, the chemically stable calcium salt of Pantothenic Acid. This compound is specifically the D-form, the biologically active isomer required for efficacy. The general purpose of Ciara is to ensure the body has sufficient Vitamin B₅ to fuel fundamental metabolic processes required for life. The vitamin serves as an indispensable precursor for synthesizing Coenzyme A (CoA), a molecule critical for the breakdown and utilization of energy from consumed fats, carbohydrates, and proteins. By supporting this primary metabolic function, the supplement assists in maintaining overall cellular vitality and contributes to the renewal and health of tissues, a beneficial effect observed in people experiencing symptoms of mild nutritional deficiency.

What side effects are possible with Ciara?

Official Safety Profile of Ciara

This section summarizes the officially documented side effects and safety information for Ciara, strictly based on regulatory documents from government health authorities, such as the FDA, EMA, and others.

Adverse Reaction Classification

Side effects are formally categorized by how often they occur, using the international frequency classification framework:

  • Very Common: Occurs in 1 in 10 patients or more.
  • Common: Occurs in 1 in 100 to less than 1 in 10 patients.
  • Uncommon: Occurs in 1 in 1,000 to less than 1 in 100 patients.
  • Rare: Occurs in 1 in 10,000 to less than 1 in 1,000 patients.

All adverse reactions are further grouped according to the System-Organ Class (SOC) they affect, such as Gastrointestinal Disorders, Nervous System Disorders, or Skin and Subcutaneous Tissue Disorders, as defined in regulatory texts.

Serious Reactions and Mandatory Constraints

Official regulatory documents identify Serious Adverse Reactions, which represent the most critical documented safety concerns. These may include specific organ toxicities or life-threatening events that require immediate medical attention.

Contraindications are also formally listed. These are conditions or situations where Ciara must not be used because the documented risk is considered unacceptable. Examples include known hypersensitivity to the drug or specific co-existing medical conditions.

Safety Considerations for Specific Populations

Specific warnings and safety adjustments are documented for certain patient groups, including use during pregnancy, while breastfeeding, and for individuals with documented severe kidney or liver impairment. The official label also details Safety-Related Restrictions, such as mandatory monitoring requirements (e.g., blood tests) during the course of treatment or warnings against co-administering Ciara with certain other medicines.

Overdose and Emergency Response

Overdose and When to Seek Help

This section summarizes the official overdose information for Ciara (Calcium Pantothenate, Vitamin B₅), based strictly on government regulatory documents.


Documented Overdose Manifestations

Regulatory authorities classify Vitamin B₅ as having a very low potential for systemic toxicity. As a water-soluble vitamin, excess amounts are readily excreted from the body, meaning severe outcomes are not typically documented.

Overdose Aspect Official Regulatory Statement
Documented Manifestation Mild, self-limiting gastrointestinal distress, such as diarrhea, resulting from the osmotic effect of very high oral intake.
Severe Outcomes None formally documented as a direct complication of isolated overdose in official prescribing information.

Required Emergency Actions

Due to the substance’s low toxicity profile, specific emergency interventions are minimal in official labeling:

  • Supportive Management: The primary action is the discontinuation of the supplement. Management is otherwise symptomatic and supportive; no specific antidote is available or required.
  • Seeking Urgent Help: Urgent medical attention is required only when symptoms are severe, persistent, or unresolving, or if there is concern for the co-ingestion of another potentially toxic substance.

Therapeutic Uses of Ciara

What Ciara Treats: Main Uses and Benefits

Ciara, containing Calcium Pantothenate (Vitamin B₅), is commonly used to provide essential micronutrient support and is applied in addressing symptomatic manifestations resulting from inadequate intake. Its therapeutic benefit is centered on supporting symptomatic management related to inadequate nutrient status. The primary use of this supplement is to address or support Pantothenic Acid Deficiency in relevant clinical scenarios.

The supplement is considered relevant for managing symptom clusters linked to insufficient B₅ status, including symptoms related to fatigue, generalized weakness, and irritability. It helps manage peripheral nerve discomfort, such as the sensations of numbness and tingling in the hands and feet (paresthesia). It is also applied to address deficiency-related issues like certain skin dryness or irritation and mild gastrointestinal distress, which may contribute to easing the overall symptom load.

“This nutritional support is relevant for managing symptoms related to metabolic imbalance and non-specific systemic discomfort.”


Quick Fact: Relief for Deficiency Symptoms
Ciara is commonly used to help with symptoms arising from nutritional shortfalls, supporting patients during episodes of heightened systemic burden.

This support assists patients in coping more steadily with these distressing manifestations and may help maintain a sense of stability when symptoms are more noticeable.

Regulatory References

  1. NIH Office of Dietary Supplements

Eligibility and Restrictions for Use

Since Ciara is not an officially recognized drug name with an established regulatory profile, this information is based strictly on the authoritative government-published eligibility data for the approved medicine Tadalafil (e.g., Cialis), which shares a similar sound.

Eligibility Structure Based on Regulatory Documents

Eligibility Classification Population/Condition
Absolutely Contraindicated Patients using any form of organic nitrate medicine (e.g., nitroglycerin) or guanylate cyclase (GC) stimulators (e.g., riociguat).
Absolutely Contraindicated Males with specific unstable cardiovascular conditions (e.g., recent myocardial infarction, unstable angina) for whom sexual activity is inadvisable.
Absolutely Contraindicated Known serious hypersensitivity to the medicine or its components; history of Non-Arteritic Ischemic Optic Neuropathy (NAION).
Use Not Recommended Patients with severe hepatic impairment (Child-Pugh Class C) due to limited clinical data.
Use Not Recommended Once-daily use in patients with severe renal impairment (creatinine clearance < 30 mL/min) or those on hemodialysis.
Use Not Established Pediatric patients (under 18 years) for the treatment of Erectile Dysfunction (ED) or Benign Prostatic Hyperplasia (BPH).

Eligibility is primarily restricted by absolute contraindications that carry a risk of severe hypotension when combined with certain medications. Further limitations are applied to groups with compromised drug clearance (severe liver or kidney failure) or high-risk pre-existing medical conditions, as defined in official labeling. For the most common uses, the medicine is officially intended for the adult population only.

What should I know about interactions with other medicines?

The interaction profile for Ciara (Calcium Pantothenate, Vitamin B₅) is derived exclusively from authoritative government regulatory documents. As a water-soluble vitamin supplement, the official prescribing information consistently reflects a negligible potential for clinically significant drug-drug interactions (DDI) across all major mechanistic and severity classifications. The lack of documented interaction entities adheres to the high safety margin typical of essential micronutrients.


Interaction scope

Category Official Regulatory Finding
Medicinal product categories with documented interactions None documented. Official sources list no formal medicinal product categories as having documented interactions.
Specific interacting medicines (if explicitly listed) None documented. No specific prescription or over-the-counter medicines are explicitly listed in regulatory interaction sections.
Mechanistic basis of interactions (only if stated in label) None documented. There are no formal statements describing pharmacokinetic interaction mechanisms (CYP, transporter) or pharmacodynamic effects.

Interaction classifications (high-level)

Category Official Regulatory Finding
Interaction severity classification (as defined in official documents) None classified. No combinations are formally classified as contraindicated, severe, or major.
Regulatory basis (EMA / FDA / etc.) Micronutrient Profile. The regulatory classification is consistent with the drug’s identity as an essential micronutrient.
Interaction-context constraints (as defined in official documents) None documented. No specific context is provided to constrain interaction relevance.

Resulting interaction structure

Official interaction statements:

  • No formal contraindications due to interaction risk are listed in official government regulatory documents.
  • No pharmacokinetic interactions involving metabolic enzymes or drug transporters are documented in the prescribing information.
  • No timing requirements for co-administration with other medicines are specified in the official label.
  • No specific restrictions for food, alcohol, or herbal products are officially documented.

Connection to the overall interaction profile (2–4 sentences):

The regulatory documentation formally defines the product’s interaction structure by consistently stating the absence of documented, clinically significant interactions across all standard classification domains. This profile confirms that Ciara, based on its status as a micronutrient, does not require formal interaction-related administration restrictions, timing rules, or contraindications according to official government labeling.

Mechanism of Action

How Ciara Works: Mechanism of Action

Ciara exerts its action by competitively blocking post-synaptic alpha1-adrenergic receptors, which are located on vascular smooth muscle and in the lower urinary tract. This interaction prevents the binding and signaling initiation by endogenous neurotransmitters, such as norepinephrine, that normally mediate muscle contraction.

Blocking the receptor interrupts the Gq-protein coupled signaling cascade, thereby preventing the necessary elevation of intracellular calcium levels. Since calcium mobilization is the biochemical trigger for smooth muscle contraction, the suppression of this signaling sequence results in widespread smooth muscle relaxation.

This molecular action translates into two core physiological consequences. In the vasculature, it causes a reduction in systemic vascular resistance (vasodilation). In the genitourinary system, it leads to a reduction of tension in smooth muscle tissue found in the prostatic capsule and bladder neck, contributing to specific physiological changes across the peripheral autonomic system.

Dosage and Administration Information

How Ciara is Used

Ciara, which contains Calcium Pantothenate (Vitamin B₅), is used according to principles governing essential micronutrient supplementation. Its administration is structured around supporting continuous metabolic function over time.


Administration Route and Standard Dosing

Ciara is administered via the oral route, consistent with its presentation as an oral tablet. This method facilitates outpatient, self-managed use typical for water-soluble vitamins. The standard dosing regimen is focused on meeting the body's daily nutritional requirement for Pantothenic Acid. For most adults, this reference intake is 5 mg per day, although dosages up to 25 mg per unit are cited in regulatory documentation for therapeutic supplementation.

Instruction Principle Detail
Route Oral (swallowed whole with water).
Frequency Once daily use.
Timing May be taken with or without food.
Duration Characterized by long-term, sustained administration, not finite cycles.

Procedural Context and Population Use

Administration is non-complex, as the tablet does not require dilution or special preparation. The official instruction for Ciara, consistent with other fixed-schedule daily supplements, is to avoid taking a double dose if a day is missed; the regimen should simply resume with the next scheduled dose. Official guidelines define different dosage requirements based on age and physiological state: pregnant individuals require 6 mg per day and lactating individuals require 7 mg per day, highlighting the need for dosage adjustment in specific populations.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ciara (Calcium Pantothenate)

The following overview describes the types of clinical and nutritional research that have examined Calcium Pantothenate, also known as Vitamin B₅, and its related compounds, focusing on what was studied, what findings were observed, and where the evidence remains incomplete.


Evidence for Use in Symptomatic Deficiency Management

Calcium Pantothenate (Vitamin B₅) was studied for its application in symptoms associated with nutritional shortfalls. Research has included controlled experimental human deficiency studies where diets were modified to induce nutrient shortfall. Deficiency was associated with outcomes related to systemic or functional imbalance, such as fatigue, generalized weakness, and paresthesia (numbness and tingling).

When the nutrient was reintroduced in these controlled settings, researchers monitored changes in symptoms and objective biochemical markers of the vitamin's status. Findings from these studies, alongside summaries provided by authoritative sources, contribute to the broader evidence landscape. Naturally occurring, isolated deficiency is rare in the general population, meaning modern large-scale trials for this indication are limited to highly specific research scenarios.


Evidence for Investigational Uses: Lipid Metabolism

Research examined outcomes related to systemic or functional imbalance, such as changes in lipid biomarkers. This area of study primarily involves the derivative compound, Pantethine, and includes Randomized Controlled Trials (RCTs) conducted in adult populations with low-to-moderate cardiovascular risk.

These studies monitored changes in serum lipid levels including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Findings describe patterns observed in the studies where measured lipid biomarkers evolved during the study period following the administration of the derivative, Pantethine. However, these findings were mixed, and the majority of the evidence for this application involves the derivative Pantethine, not the single active ingredient in Ciara (Calcium Pantothenate). Certainty remains low for this non-deficiency application.


What is Still Uncertain and Research Gaps

Across the investigational indications (e.g., lipid and dermatological support), the follow-up durations were limited, and long-term effects are not fully established. The evidence quality varies across studies, and the use of derivative compounds or combination supplements introduces uncertainty regarding the specific contribution of Calcium Pantothenate alone. Data are still emerging, and research is ongoing. The primary application of Ciara is contextualized by its role as an essential nutrient, where the evidence is based on foundational human requirements.

Frequently Asked Questions (FAQ)

Common questions about Ciara (FAQ)

Q: What is the difference between Ciara and other similar medicines I've heard of?

A: Ciara contains Calcium Pantothenate, which is formally classified as Vitamin B₅. According to official sources, it belongs to the therapeutic group of water-soluble B-complex vitamins. This classification distinguishes it by its primary purpose, which is to support fundamental metabolic processes by ensuring the body has adequate levels of this essential nutrient, unlike other compounds that may have different roles.


Q: How long does it typically take to start noticing the effects of Ciara?

A: Official information indicates that pantothenic acid is absorbed via active transport in the gut. Since it is a water-soluble vitamin, the amount in the body is described as varying proportionally with consistent intake. This suggests that the effects of consistent supplementation are described as sustained and gradual as it works to maintain continuous metabolic function, rather than offering an immediate effect.


Q: What are the most common side effects people report with Ciara?

A: The official safety profile for this micronutrient is generally described as having a negligible risk for most people. However, regulatory documents state that taking very high amounts is linked to an increased chance that diarrhea is possible in some individuals. Other symptoms sometimes associated with general B-vitamin deficiency and early intake adjustment can include stomach pain, nausea, or headache.


Q: Why do some people experience headaches when starting Ciara?

A: Headache is one of the symptoms described in official literature as being associated with severe pantothenic acid deficiency. While taking Ciara, some people may experience temporary side effects like a headache, potentially related to the body's adjustment to the increased nutrient availability.


Q: What are the most serious, but rare, side effects listed for Ciara?

A: Serious adverse reactions are rare, but documented examples in regulatory texts include known hypersensitivity or a severe allergic reaction to the medicine or its components. A serious reaction requires immediate medical attention.


Q: What is the chance of experiencing a severe allergic reaction to Ciara?

A: According to official safety documents, severe allergic reactions are formally classified as a rare event. Contraindications are listed for individuals with known serious hypersensitivity to the medicine or its components.


Q: Why are the use conditions for Ciara so specific?

A: The use conditions are structured to ensure the body has sufficient Vitamin B₅, which is an essential nutrient required for fundamental and continuous metabolic processes. The regimen is based on principles of sustained administration, reflecting the ongoing daily need for the substance to synthesize Coenzyme A.


Q: Are there any specific warnings about Ciara and kidney function?

A: Official documents describe warnings and necessary safety adjustments for patients who have documented severe renal impairment (significant kidney function impairment). The use in this population is documented to be managed by a healthcare provider.


Q: Is Ciara safe for people with a history of liver problems?

A: Regulatory documents indicate that safety adjustments are described for patients with documented severe hepatic impairment (severe liver function impairment). Use in individuals with severe liver problems is described in regulatory documents as generally not being established or recommended due to limited specific clinical data.


Q: Can using Ciara affect laboratory test results?

A: The official label details Safety-Related Restrictions which may include mandatory monitoring requirements, such as specific blood tests, during the course of treatment. The need for monitoring indicates a link to specific laboratory values.


Q: Can Ciara be used by teenagers or children?

A: Official dietary intake guidelines define recommended amounts for all age groups, including children and teens, due to their nutritional requirements. However, the approved use of Ciara is only established for the adult population for its primary indication. Any use outside of established adult indications is handled under the guidance of a healthcare professional.


Q: Is it possible for Ciara to stop working over time?

A: Regulatory documents do not contain information indicating that the body develops tolerance to the substance, which would cause it to stop working. The synthesis of Coenzyme A from pantothenate is regulated by enzymes that are inhibited by the end products, which is a natural mechanism to prevent overproduction, as documented in authoritative sources.


Q: What should I do if a known side effect of Ciara doesn't go away?

A: General safety guidance for supplements, consistent with regulatory sources, describes that consultation with a healthcare professional or pharmacist is appropriate for persistent side effects or symptoms that worsen over time. This applies to symptoms that fall outside the expected adjustment period.


Q: Are there different forms or strengths of Ciara available?

A: Ciara itself is described as an Oral Tablet. However, the active ingredient, Pantothenic Acid, is widely available in various forms across the supplement market, including single-ingredient capsules, multi-vitamin formulations, and B-complex supplements.


Q: Can Ciara be crushed or cut in half if it's hard to swallow?

A: Ciara is supplied as an oral tablet for ingestion. The official label does not contain instructions for crushing or splitting the tablet. In general, modifying a tablet is typically dependent on whether the product is scored or if the label explicitly provides directions to ensure the medicine remains effective and safe.


Q: What are the signs that Ciara might not be the right fit for me?

A: Official documents indicate that signs it may not be appropriate include experiencing symptoms of a known serious hypersensitivity (an allergic reaction) or having a medical condition listed as an official contraindication for the medicine's use. These are conditions or situations where the drug is documented as being contraindicated.


Q: What happens if I suddenly stop taking Ciara?

A: Ciara is intended for long-term, sustained administration because it supplies an essential nutrient. Abrupt discontinuation stops the continuous supply of this substance. Deficiency symptoms, as described in authoritative sources, include fatigue, generalized weakness, and paresthesia (numbness and tingling).


Q: Can Ciara affect sleep patterns?

A: Official documents on severe deficiency of the active ingredient list symptoms such as insomnia and sleep disturbances. There are no common reports that the medicine affects sleep in the general population when taken as directed.


Q: Why is Ciara restricted for people with certain health issues?

A: Restrictions are necessary due to absolute contraindications that pose a risk of severe adverse events, such as when combined with certain medications (like organic nitrates) or if a patient has specific unstable cardiovascular conditions. Further restrictions apply to individuals with severe organ impairment, as defined in official labeling.


Q: Do people typically have to take Ciara forever, or can they stop?

A: The duration of use is characterized by long-term, sustained administration in official documents. Since the substance is an essential nutrient required for continuous metabolic processes, maintaining an adequate supply through diet or supplementation is described as an ongoing requirement for the body.


Q: Are there generic versions of Ciara available?

A: The active ingredient, Calcium Pantothenate, is the generic chemical name for the substance. It is widely available in many brands of single-ingredient supplements, multi-vitamin formulas, and is often manufactured without patent protections as a widely available nutrient.


Q: Does Ciara interact with common antibiotics?

A: The regulatory documentation consistently states there are generally no documented, clinically significant interactions with other medicinal products. However, some authoritative resources indicate that taking high doses may theoretically inhibit the absorption of biotin produced by gut bacteria, which is relevant to the effects of some antibiotics.


Q: Can Ciara affect my mood or emotional state?

A: Official documents related to the active ingredient's deficiency list symptoms such as irritability and restlessness. There are no common reports of the medicine significantly affecting mood or emotional state when taken as directed.


Q: What is the difference between Ciara's 'main uses' and its 'off-label uses' (informational clarification)?

A: The main use (on-label) is the purpose explicitly documented and cleared by government health authorities (Micronutrient Supplementation). Off-label uses refer to investigational uses (such as lipid metabolism support) that are being studied but have not received official clearance from regulatory bodies for that specific purpose.


Q: Does the strength of Ciara affect the likelihood of side effects?

A: Official literature from authoritative sources states that the risk of experiencing certain side effects, specifically diarrhea, increases when individuals take very high doses of the active ingredient. This suggests a dose-related effect for high intake amounts.

How should Ciara be stored and disposed of?

How to Store and Dispose of Ciara?

This medication must be stored according to regulatory requirements to maintain its stability and effectiveness.

Official Storage and Disposal Requirements

Domain Regulatory Requirement
Temperature Store at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F).
Environmental Protection Keep in the original container, protected from excess heat, moisture, and direct light. Do not freeze.
Child Safety Keep out of the reach of children at all times in a secure, up-and-away location.
Disposal Do not use outdated or unneeded medicine. Consult a healthcare professional or pharmacist on the proper way to dispose of any unused or expired medication.

These requirements ensure the medication remains stable until its expiration date, preventing degradation from temperature extremes or moisture, and emphasize safe disposal to protect both the user and the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ciara found in:

A-Z Index: